The article titled “A cell death screen identifies macrophage-depleting agents with therapeutic potential” is available as a preprint on bioRxiv (DOI: https://doi.org/10.64898/2026.09.17.752341). The document is explicitly noted as not peer reviewed. The supplied source text contains the article header, author list, affiliations, and links to the abstract, full PDF, and supplementary material on the bioRxiv site.
The substantive abstract text, detailed methods, results, figures, and conclusions were not included in the provided source content. Therefore, specific experimental findings, the identity of any macrophage-depleting agents, quantitative outcomes, and authors’ interpretations are not reported here.
The preprint lists multiple contributors from primarily the Medical University of Vienna, with additional authors affiliated with the University of Vienna and CeMM. Lead and contributing authors include Paul Ettel, Stephan Forisch, Manuela Traeger, Mario Mazic, Hannah K. Mayr and others. Institutional affiliations are provided for each author in the article metadata presented on bioRxiv.
For correspondence the article lists Thomas Weichhart at the Medical University of Vienna (thomas.weichhart@meduniwien.ac.at). No further contact details or correspondence notes are present in the supplied text.
The title indicates the project employed a cell death screen to identify agents that deplete macrophages and that these agents may have therapeutic potential. From the title alone, the scope appears to combine a screening approach (likely assessing cytotoxicity, survival, or death pathways) with an interest in modulating macrophage populations for therapeutic uses.
However, the supplied source does not include the experimental design, screening library or platform, cell types or models used (in vitro, ex vivo, in vivo), the criteria used to call hits, or any validation steps. Nor are candidate compounds or classes, their potency, selectivity, or toxicity described in the provided text.
The provided metadata includes links to the article abstract, full PDF preview, and supplementary material hosted on bioRxiv. Those linked resources are likely to contain the detailed abstract, methods, results, figures, and supplemental data necessary to evaluate the screening approach, identified agents, mechanistic insights, and any reported therapeutic contexts. These materials were not included in the source body supplied for this rewrite.
The text supplied here lacks the core scientific content that would allow independent evaluation or clinical interpretation. Specifically missing are:
Because these elements are absent from the provided source excerpt, no claims about efficacy, safety, or specific therapeutic use can be summarized here without consulting the full preprint and supporting data.
Based only on the article title and the fact that it is a research preprint, the work likely aims to expand tools for selectively removing or modulating macrophage populations. Selective macrophage depletion can be of interest in multiple therapeutic contexts (for example, modulating tumor-associated macrophages, treating inflammatory conditions, or reshaping immune responses). However, the current supplied source does not report which contexts the authors propose, nor does it provide data to support translation.
Appropriate next steps to assess the reported findings would include:
Note: This summary and rewrite only reflect the material included in the supplied source text. Specific experimental results, identified compounds, and authors’ conclusions were not present in that text and therefore are not reported here. For complete information, consult the full preprint and supplementary files on the bioRxiv page referenced above.